Exploring molecular mechanisms and genetic dysregulation in aging and age-associated diseases

FHS
August 10, 2023
12:12 pm

Researchers review existing data on the molecular basis of senescence and neurodegeneration in age-related brain diseases.

Harmony Biosciences’ Wakix fails PhIII hypersomnia study; Florida gene therapy startup downsizes

Plus Phase II data on ABION’s MET tyrosine kinase inhibitor, and 60 Degrees Pharmaceuticals giving up on repurposing its antimalarial drug for Covid-19. Harmony Biosciences’

October 14, 2023

Toripalimab by Shanghai Junshi Biosciences for Bladder Cancer: Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

November 19, 2023

U.S. Doctors Trapped in Gaza Hospital by Israeli Assault

The 35 American and other international doctors came to Gaza in volunteer teams to help one of the territory’s few hospitals still functioning. They brought

May 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.